Beyond Symptom Relief: Physician Empathy Outperforms Clinical Severity in Predicting Quality of Life for Patients Undergoing Botulinum Toxin Therapy
Objective: To evaluate the impact of patient-perceived physician empathy on health-related quality of life (HRQoL), treatment satisfaction, and clinical outcomes in patients receiving Botulinum Neurotoxin…IncobotulinumtoxinA for the Treatment of Lower Limb Spasticity in Children and Adolescents with Cerebral Palsy Evaluation of Lower Limb IncobotulinumtoxinA Efficacy (ELLIE)
Objective: To investigate the use of incobotulinumtoxinA in the treatment of lower limb spasticity in children and adolescents with cerebral palsy (CP). Background: Spasticity associated…Are All Toxins Created Equal? Real-world analysis of Abo-, Inco- and Ona- BoNT-A from prospective LIVEchart over 7 years
Objective: To compare dosing, duration of action, and patient-reported outcomes across inco-, abo- and ona- BoNT (botulinum toxin) in cervical dystonia (CD), hemifacial spasm (HFS),…Hypersensitivity Reaction to Abobotulinumtoxin: A Case Report
Objective: To report a case of hypersensitivity reaction to abobotulinumtoxinA injections for spasticity in a patient who did not have hypersensitivity to onabotulinumtoxinA and raise…Characteristics of IncobotulinumtoxinA Treatment for Limb Spasticity in a Real-World Setting: Dosing and Muscles Injected
Objective: This study described incobotulinumtoxinA doses and muscles injected in a real-world setting for patients with limb spasticity (LS). Background: IncobotulinumtoxinA is approved to treat…Hemimasticatory Spasm: A Report of Two Cases
Objective: We present two HMS patients with distinct Doppler ultrasonography findings in the involved masseter muscle, however, both responded favorably to botulinum toxin A injections.…Goal Attainment and Ambulation With Increasing Doses of IncobotulinumtoxinA: A Post Hoc Analysis of the TOWER Study
Objective: To evaluate goal attainment and ambulation in a subpopulation of TOWER study patients treated with UK licensed doses of incobotulinumtoxinA (incoA) for injection cycles…Moderate-to-severe upper limb spasticity patterns in the elderly are improved following treatment with incobotulinumtoxinA: a pooled analysis
Objective: To compare upper limb spasticity (ULS) severity changes from baseline in different spastic patterns at 4 weeks and 12 weeks post-injection of incobotulinumtoxinA (incoA)…Improvement in upper limb spasticity patterns in the elderly following treatment with incobotulinumtoxinA: a pooled analysis
Objective: To compare changes from baseline in upper limb spasticity (ULS) severity in different spastic patterns at 4 weeks and 12 weeks post-injection of incobotulinumtoxinA…Identifying and Managing Spasticity in Neurological Shoulder Dysfunction
Objective: To understand this discrepancy between diagnosis and treatment of spasticity in neurological shoulder dysfunction, we formed an expert panel to establish consensus and provide…
- 1
- 2
- 3
- …
- 8
- Next Page »